6533b839fe1ef96bd12a5b1b
RESEARCH PRODUCT
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
Richard F. SchlenkVerena I. GaidzikH-a HorstWalter FiedlerDavid NachbaurDoris KraemerGuido KobbeVeronica TeleanuDaniela WeberBernd HertensteinJürgen KrauterAlexander BurchardtHartmut DöhnerPeter BrossartMark RinghofferKatharina GötzeHelmut R. SalihPeter PaschkaHans-juergen SalwenderStephan KremersMichael HeuserMichael LübbertK DöhnerFelicitas TholM. WattadArnold GanserHeinz KirchenP FrechGerhard HeldGerald WulfElisabeth KollerThomas Fischersubject
OncologyAdultMaleCancer Researchmedicine.medical_specialtyMyeloidAdolescentmedicine.medical_treatmentSalvage therapyHematopoietic stem cell transplantationOutcome (game theory)03 medical and health sciencesYoung Adult0302 clinical medicineText miningRecurrencehemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansYoung adultLetter to the EditorAgedAged 80 and overSalvage Therapybusiness.industryHematopoietic Stem Cell TransplantationMyeloid leukemiaHematologyMiddle Agedmedicine.diseasePrognosisLeukemiaLeukemia Myeloid Acutemedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisFemalebusiness030215 immunologydescription
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
year | journal | country | edition | language |
---|---|---|---|---|
2017-02-01 | Leukemia |